Matsubara J, Yamada Y, Hirashima Y, Takahari D, Okita NT, Kato K, Hamaguchi T, Shirao K, Shimada Y, Shimoda T:

Impact of insulin-like growth factor type 1 receptor (IGF-1R), epidermal growth factor receptor (EGFR), and HER2 expressions on outcomes of patients with gastric cancer.

Clin Cancer Res 2008; 14: 3022-3029.

Matsubara J, Yamada Y, Nakajima TE, Kato K, Hamaguchi T, Shirao K, Shimada Y, Shimoda T:

Clinical significance of insulin-like growth factor type 1 receptor and epidermal growth factor receptor in patients with advanced gastric cancer.

Oncology 2008; 74: 76-83.

Matsubara J, Shimada Y, Takashima A, Takahari D, Hirashima Y, Okita NT, Nakajima TE, Kato K, Hamaguchi T, Yamada Y, Shirao K:

A phase I study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel (FLTAX) as first-line therapy for advanced gastric cancer.

Jpn J Clin Oncol 2008; 38: 540-546.

Matsumoto S, Nishimura T, Kanai M, Mori Y, Nagayama S, Kawamura J, Nomura A, Miyamoto S, Kitano T, Ishiguro H, Yanagihara K, Teramukai S, Sakai Y, Chiba T, Fukushima M.

Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer. A single-institution outcome study.

Chemotherapy 2008;54:395-403.

Yamada A, Sasaki H, Aoyagi K, Sano M, Fujii S, Daiko H, Nishimura M, Yoshida T, Chiba T, Ochiai A.

Expression of cytokeratin 7 predicts survival in stage I/IIA/IIB squamous cell carcinoma of the esophagus.

Oncol Rep. 2008;20(5):1021-7.

Muto M, Ochiai A, Yoshida S.

Detection of superficial cancer in the oropharyngeal and hypopharyngeal mucosal sites and the value of NBI at qualitative diagnosis. In “Advanced Digestive Endoscopy: comprehensive Atlas of High Resolution Endoscopy and Narrowband lmaging”,P35-48, Edited by Jonathan cohen.

Blackwell publishing 2007

Minashi K. Muto M. Ohtsu A.

Non-surgical treatment of superficial esophageal squamous cell carcinoma.

Esophagus. 4,159-164, 2007

Takeuchi S, Ohtsu A, Doi T, Kojima T, Minashi K, Mera K, Yano T, Tahara M, Muto M, Nihei K.

A retrospective study of definitive chemoradiotherapy for elderly patients with esophageal cancer.

Am J Clin Oncol. ;30(6):607-11, 2007

Minegishi Y, Tsukino H, Muto M, Goto K, Gemma A, Tsugane S, Kudoh S, Nishiwaki Y, Esumi H.

Susceptibility to lung cancer and genetic　polymorphisms in the alcohol metabolite-related　enzymes alcohol dehydrogenase 3, aldehyde　dehydrogenase 2, and cytochrome p450 2E1 in the Japanese population.

Cancer 110:353-362, 2007

Fuse N, Doi T, Ohtsu A, Takeuchi S, Kojima T, Taku K, Tahara M, Muto M, Asaka M, Yoshida S.

Feasibility of oxaliplatin and infusional fluorouracil/leucovorin (FOLFOX4) for Japanese patients with unresectable metastatic colorectal cancer.

Jpn J Clin Oncol.;37(6):434-9, 2007